首页> 外文期刊>Biochemical and Biophysical Research Communications >C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells
【24h】

C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells

机译:C-Myc通过上调胶质母细胞瘤多形细胞中的miR-26a负控制肿瘤抑制因子PTEN

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The c-Myc oncogene is amplified in many tumor types. It is an important regulator of cell proliferation and has been linked to altered miRNA expression, suggesting that c-Myc-regulated miRNAs might contribute to tumor progression. Although miR-26a has been reported to be upregulated in glioblastoma multiforme (GBM), the mechanism has not been established. We have shown that ectopic expression of miR-26a influenced cell proliferation by targeting PTEN, a tumor suppressor gene that is inactivated in many common malignancies, including GBM. Our findings suggest that c-Myc modulates genes associated with oncogenesis in GBM through deregulation of miRNAs via the c-Myc-miR-26a-PTEN signaling pathway. This may be of clinical relevance.
机译:c-Myc癌基因在许多类型的肿瘤中都会扩增。它是细胞增殖的重要调节剂,并与改变的miRNA表达有关,表明c-Myc调节的miRNA可能有助于肿瘤进展。尽管已报道miR-26a在多形胶质母细胞瘤(GBM)中上调,但该机制尚未建立。我们已经表明,miR-26a的异位表达通过靶向PTEN(一种在许多常见恶性肿瘤(包括GBM)中失活的肿瘤抑制基因)而影响细胞增殖。我们的发现表明,c-Myc通过经由c-Myc-miR-26a-PTEN信号通路的miRNA失调来调节与GBM中肿瘤发生有关的基因。这可能与临床有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号